NCT07621575Completed
Active Drainage vs. Passive Drainage in MRM
Comparison Between Active Drainage And Passive Drainage In Post-Operative Seroma Formation After Modified Radical Mastectomy In Female Patients With Breast Carcinoma: A Prospective Randomized Controlled Trial.
Source: ClinicalTrials.gov · Last updated 2 Jun 2026
Brief summary (registry, in English)
The aim of the study is to compare between active drainage and passive drainage in post-operative seroma formation after modified radical mastectomy in female patient with breast carcinoma as regard of: Primary Outcomes: 1. Daily drain output (measured in mL/day). 2. Duration of the drain in place. 3. Amount of seroma aspiration after the drain removal. 4. Number of days till the last seroma aspiration. Secondary Outcomes: 1. Flap necrosis. 2. Surgical site infection. 100 female divided into two equal groups: * Group A: Active drainage group (50 patients). * Group B: Passive drainage group (50 patients). After MRM ,drain output was measured daily using a graduated jar by nurse during hospital stay which was a one to two days in an average and then by patient himself. All the data was recorded on a paper sheet. In passive drain, breast and axilla outcomes were combined together as one read to be equal to one active drain gar. Twice per week, I checked this reading by myself and reported any complications).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 157 (actual)
- First submitted
- 7 May 2026
- Start date
- 30 May 2024
- Primary completion date
- 10 May 2025
- Lead sponsor
- MOHAMED GAMAL AHMED ARAKEEB
- Diseases
- Childhood cancers
- NCT number
- NCT07621575
What you commit to
- Study type: Interventional
- Participants enrolled: 157
- From 30 May 2024 to the primary completion date, 10 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- • Previous breast surgery.
- Active infection.
- Recurrent or metastatic breast cancer (Stage IV).
- Un-controlled diabetes mellitus (HbA1C \>7).
- Coagulopathy disease.
- Use of anticoagulant or antiplatelet medications.
- Bilateral breast cancer.
- Loss to follow-up within one month of drain removal.
- Pregnancy.
- Male breast cancer patients.
Who the study is looking for
- Female patient diagnosed with breast carcinoma planned for MRM
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kafrelsheikh University Coordinator of this site? Confirm its status | Kafr ash Shaykh | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.